Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential cardioprotective mechanisms of vitamin D?
Mateusz OzorowskiMichał WicińskiŁukasz WróbelAnna Fajkiel-MadajczykPublished in: Nutrition & metabolism (2022)
levels in obese people reduces the concentration of pro-inflammatory factors associated with cardiovascular diseases. Reducing inflammation and the potential impact on vascular reactivity leads to the conclusion that cholecalciferol supplementation in obese patients may benefit the cardiovascular system.
Keyphrases
- obese patients
- bariatric surgery
- roux en y gastric bypass
- gastric bypass
- weight loss
- end stage renal disease
- adipose tissue
- cardiovascular disease
- ejection fraction
- metabolic syndrome
- newly diagnosed
- type diabetes
- chronic kidney disease
- oxidative stress
- prognostic factors
- vascular endothelial growth factor
- human health
- endothelial cells
- climate change
- coronary artery disease
- risk assessment
- patient reported outcomes